Published in Eur Radiol on September 06, 2001
Liver cirrhosis. Lancet (2008) 6.11
Microbubble ultrasound contrast agents: an update. Eur Radiol (2007) 1.57
Quantitative assessment of the magnitude, impact and spatial extent of ultrasonic clutter. Ultrason Imaging (2008) 1.44
Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol (2013) 1.35
A motion-based approach to abdominal clutter reduction. IEEE Trans Ultrason Ferroelectr Freq Control (2009) 1.24
Application of a second-generation US contrast agent in infants and children--a European questionnaire-based survey. Pediatr Radiol (2012) 1.10
Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results. Eur Radiol (2006) 1.06
The status of contemporary image-guided modalities in oncologic surgery. Ann Surg (2015) 0.97
Contrast-enhanced ultrasonograpic findings in pancreatic tumors. Int J Med Sci (2008) 0.95
Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results. Eur Radiol (2005) 0.93
Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives. World J Gastroenterol (2014) 0.91
Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol (2006) 0.90
Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions. Eur Radiol (2006) 0.89
Photoacoustic and ultrasound imaging using dual contrast perfluorocarbon nanodroplets triggered by laser pulses at 1064 nm. Biomed Opt Express (2014) 0.88
Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound. Eur Radiol (2003) 0.86
Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol (2005) 0.86
Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. Eur Radiol (2003) 0.84
Imaging of aortic abnormalities with contrast-enhanced ultrasound. A pictorial comparison with CT. Eur Radiol (2007) 0.82
Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol (2003) 0.82
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Clin Mol Hepatol (2015) 0.81
Quantitative evaluation of muscle perfusion with CEUS and with MR. Eur Radiol (2007) 0.81
Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT. Br J Radiol (2010) 0.81
Real-time, contrast-specific sonography imaging of acute splenic disorders: a pictorial review. Emerg Radiol (2004) 0.80
Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol (2006) 0.79
Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol (2004) 0.79
Four-dimensional volume contrast ultrasound imaging of the gallbladder compared with tissue harmonic imaging: preliminary experience. Eur Radiol (2004) 0.78
Double-scattering/reflection in a single nanoparticle for intensified ultrasound imaging. Sci Rep (2015) 0.77
Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology (2015) 0.76
Resolution and brightness characteristics of short-lag spatial coherence (SLSC) images. IEEE Trans Ultrason Ferroelectr Freq Control (2015) 0.75
Molecular imaging in oncology. Cancer Imaging (2004) 0.75
Focal hepatic lesions characterisation by different sonographic techniques: a prospective analysis. J Ultrasound (2015) 0.75
Christian Doppler and the influence of his work on modern medicine. Wien Klin Wochenschr (2004) 0.75
Early liver cancer: concepts, diagnosis, and management. Int J Clin Oncol (2005) 0.75
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology (2003) 4.13
Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology (2005) 3.63
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol (2008) 3.55
Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. JAMA (2009) 3.27
80-kV pulmonary CT angiography with 40 mL of iodinated contrast material in lean patients: comparison of vascular enhancement with iodixanol (320 mg I/mL)and iomeprol (400 mg I/mL). AJR Am J Roentgenol (2012) 2.29
Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology (2005) 1.90
Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol (2010) 1.67
Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol (2003) 1.53
Ultrasonographic appearance of breast implant complications. Ann Plast Surg (2006) 1.51
Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values. Magn Reson Imaging (2010) 1.49
Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system. Invest Radiol (2008) 1.40
Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol (2011) 1.36
CT-guided radiofrequency ablation of osteoid osteoma: long-term results. Eur Radiol (2004) 1.35
Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy. Radiology (2002) 1.32
Complete response for advanced liver cancer during sorafenib therapy: case report. BMC Gastroenterol (2011) 1.30
Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl (2004) 1.21
Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol (2004) 1.18
Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol (2011) 1.15
Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol (2003) 1.15
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study. Eur J Radiol (2011) 1.09
Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study. J Vasc Interv Radiol (2010) 1.03
Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. Stroke (2005) 1.00
Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J Hepatol (2008) 1.00
Osteoid osteoma in atypical locations: the added value of dynamic gadolinium-enhanced MR imaging. Eur J Radiol (2008) 0.98
Value of opposed-phase gradient-echo technique in distinguishing between benign and malignant vertebral lesions. Eur Radiol (2001) 0.97
Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics. Magn Reson Imaging (2012) 0.96
Comparison of CT colonography vs. conventional colonoscopy in mapping the segmental location of colon cancer before surgery. Abdom Imaging (2009) 0.96
Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants. Eur J Radiol (2013) 0.95
Abdominal aortic aneurysm: contrast-enhanced US for missed endoleaks after endoluminal repair. Radiology (2004) 0.94
Radiofrequency ablation of lung malignancies: where do we stand? Cardiovasc Intervent Radiol (2004) 0.93
Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol (2007) 0.93
Guidelines for imaging focal lesions in liver cirrhosis. Expert Rev Gastroenterol Hepatol (2008) 0.92
Integrating image processing in PACS. Eur J Radiol (2009) 0.92
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma. Cancer Chemother Pharmacol (2011) 0.92
Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation. Radiology (2010) 0.91
Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours. Eur Radiol (2014) 0.90
Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. Abdom Imaging (2010) 0.90
Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US. Eur Radiol (2007) 0.90
Imaging diagnosis. Semin Liver Dis (2005) 0.90
Diagnosis of a variant of Mayer-Rokitansky-Kuster-Hauser syndrome: useful MRI findings. Abdom Imaging (2011) 0.89
Bowel preparation for CT colonography. Eur J Radiol (2013) 0.89
CT colonography versus double-contrast barium enema for screening of colorectal cancer: comparison of radiation burden. Abdom Imaging (2009) 0.89
Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovasc Intervent Radiol (2010) 0.89
Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging (2008) 0.87
CT colonography: role of a second reader CAD paradigm in the initial training of radiologists. Eur J Radiol (2010) 0.87
Post-surgical follow-up of colorectal cancer: role of contrast-enhanced CT colonography. Abdom Imaging (2010) 0.86
Image fusion of preprocedural CTA with real-time fluoroscopy to guide proper hepatic artery catheterization during transarterial chemoembolization of hepatocellular carcinoma: a feasibility study. Cardiovasc Intervent Radiol (2012) 0.86
Dependence of brain DTI maps of fractional anisotropy and mean diffusivity on the number of diffusion weighting directions. J Appl Clin Med Phys (2009) 0.86
Radiofrequency ablation of lung tumours. Insights Imaging (2011) 0.86
64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters. Eur Radiol (2010) 0.85
Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management. Cancer Manag Res (2010) 0.84
The future of PACS in healthcare enterprises. Eur J Radiol (2010) 0.84
Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients. Int J Colorectal Dis (2007) 0.83
Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography. Dig Dis Sci (2005) 0.83
Optimizing the balance between radiation dose and image quality in pediatric head CT: findings before and after intensive radiologic staff training. AJR Am J Roentgenol (2014) 0.83
Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad Radiol (2002) 0.83
Preoperative rectal cancer staging with phased-array MR. Radiat Oncol (2012) 0.82
Consensus report of the Fifth International Forum for Liver MRI. AJR Am J Roentgenol (2013) 0.82
CT colonography: same-day tagging regimen with iodixanol and reduced cathartic preparation. Abdom Imaging (2009) 0.82
Hepatocellular carcinoma: new options for image-guided ablation. J Hepatobiliary Pancreat Sci (2009) 0.81
Secretin-stimulated MR cholangio-pancreatography in the evaluation of asymptomatic patients with non-specific pancreatic hyperenzymemia. Eur J Radiol (2009) 0.81
Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study. Dig Liver Dis (2013) 0.81
Endovascular repair of abdominal aortic aneurysms: analysis of aneurysm volumetric changes at mid-term follow-up. Cardiovasc Intervent Radiol (2005) 0.81
CT colonography: patient tolerance of laxative free fecal tagging regimen versus traditional cathartic cleansing. Abdom Imaging (2011) 0.81
MR of the liver: from breakthrough to clinical application. Abdom Imaging (2012) 0.81
Abdominal aortic aneurysms: virtual imaging and analysis through a remote web server. Eur Radiol (2004) 0.81
Type II lumbar endoleaks: hemodynamic differentiation by contrast-enhanced ultrasound scanning and influence on aneurysm enlargement after endovascular aneurysm repair. J Vasc Surg (2005) 0.81
Time efficiency of CT colonography: 2D vs 3D visualization. Comput Med Imaging Graph (2006) 0.80
Efficacy and safety of a novel vascular closure device (Glubran 2 seal) after diagnostic and interventional angiography in patients with peripheral arterial occlusive disease. Cardiovasc Intervent Radiol (2012) 0.80
Real practice radiation dose and dosimetric impact of radiological staff training in body CT examinations. Insights Imaging (2013) 0.80
Complications after liver transplantation: evaluation with magnetic resonance imaging, magnetic resonance cholangiography, and 3-dimensional contrast-enhanced magnetic resonance angiography in a single session. Can Assoc Radiol J (2008) 0.80
Vasovagal reactions in CT colonography. Abdom Imaging (2007) 0.80
Giant fibrovascular polyp of the esophagus-imaging techniques for proper treatment planning: report of two cases. Abdom Imaging (2012) 0.80
Reproducibility of BOLD localization of interictal activity in patients with focal epilepsy: intrasession and intersession comparisons. MAGMA (2011) 0.80
CT perfusion of head and neck tumors: how we do it. AJR Am J Roentgenol (2010) 0.80
Magnetic resonance imaging of liver tumors. J Hepatol (2004) 0.79
Percutaneous ablation of hepatocellular carcinoma. Recent Results Cancer Res (2006) 0.79
Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc Intervent Radiol (2005) 0.79
Technical note: DTI measurements of fractional anisotropy and mean diffusivity at 1.5 T: comparison of two radiofrequency head coils with different functional designs and sensitivities. Med Phys (2011) 0.79
Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings. Abdom Imaging (2009) 0.79
Evaluation of the proximal aortic neck enlargement following endovascular repair of abdominal aortic aneurysm: 3-years experience. Eur Radiol (2003) 0.79
Vascular injuries after percutaneous renal procedures: treatment by transcatheter embolization. Eur Radiol (2003) 0.79
Contrast-Enhanced Doppler Ultrasound of Renal Artery Stenosis: Prologue to a Promising Future. Echocardiography (1999) 0.79
Correlations between virtual endoscopy and otoendoscopy of the retrotympanum. Acta Otolaryngol (2002) 0.79
3-D CT and MRI co-registration in the assessment of cochlear implantation. Med Sci Monit (2005) 0.78
Peri-intraprocedural imaging: US, CT, and MRI. Abdom Imaging (2011) 0.78
Ultrasonographic surveillance with selective CTA after endovascular repair of abdominal aortic aneurysm. J Endovasc Ther (2009) 0.78
Differentiation of benign and malignant breast microcalcifications: mammography versus mammography-sonography combination. Radiol Med (2003) 0.78
Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus. Skeletal Radiol (2011) 0.78